ImmunityBio Cash Flow Statement (2013-2025) | IBRX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-80.48M-89.39M-88.43M-91.55M-103.00M-94.83M-111.16M-108.33M-116.58M-138.21M-95.64M-233.41M-134.13M-134.58M-85.75M-59.18M-129.67M-92.57M-67.27M-61.96M
Depreciation and Depletion (Quarter)
4.00M3.70M3.60M3.80M3.90M4.10M4.60M4.20M4.20M4.10M4.10M4.00M3.90M3.90M3.60M3.30M3.40M3.40M3.30M
Share-based Compensation (Quarter)
15.30M17.86M13.84M10.18M10.02M10.18M10.63M9.35M10.88M11.06M14.45M12.77M8.27M9.64M7.49M9.04M9.54M9.65M8.88M8.75M
Deferred Taxes (Quarter)
-0.01M
Gains from Sales and Divestitures (Quarter)
0.24M0.34M
Gains from Investment Securities (Quarter)
-0.69M0.10M-12.36M3.98M-13.86M0.36M10.02M-14.27M-1.76M0.02M19.30M-31.32M0.06M-3.89M-14.90M0.82M
Asset Writedowns and Impairment (Quarter)
Non-cash Items (Quarter)
54.28M16.20M
Cash from Operations (Quarter)
-60.47M-69.59M-72.72M-71.64M-74.93M-91.25M-80.60M-90.73M-84.31M-79.77M-87.40M-115.27M-106.98M-100.35M-98.76M-85.14M-85.91M-79.80M-68.90M-70.34M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
1.55M-1.80M-0.01M-0.14M1.32M-2.63M-0.01M7.25M3.23M-3.22M0.12M0.49M0.39M0.58M0.02M0.05M0.01M0.98M1.70M
Amortization of Deferred Charges (Quarter)
0.37M5.81M2.35M7.75M11.54M12.29M11.45M7.12M5.55M5.83M6.20M5.01M
Depreciation & Amortization (CF) (Quarter)
2.97M3.98M3.69M3.60M4.09M4.44M4.50M5.23M4.68M4.68M4.58M4.56M4.55M4.41M4.46M4.14M3.83M3.88M3.95M3.87M
Change in Working Capital
Change in Receivables (Quarter)
1.03M3.14M-1.81M14.67M5.10M9.89M10.55M
Change in Inventory (Quarter)
1.81M0.15M6.31M0.17M-1.80M0.06M7.89M
Change in Account Payables (Quarter)
6.50M-3.90M-2.77M-3.55M0.80M5.74M1.03M0.44M0.67M-1.54M-2.73M-2.88M4.31M4.66M-8.92M-3.21M6.44M-6.22M-1.39M0.98M
Change in Accured Expenses (Quarter)
-1.89M-1.93M4.45M4.56M10.89M-10.29M6.65M-3.15M18.59M9.27M-1.66M-19.52M-8.92M3.30M6.23M-2.11M-12.93M8.72M5.47M1.93M
Other Working Capital Changes (Quarter)
0.93M-3.91M2.67M-3.86M1.04M-0.82M-2.53M18.86M-9.69M9.81M-0.58M0.20M0.07M0.04M0.04M-0.04M0.24M4.00M0.04M0.08M
Investing Activities
Capital Expenditures (Quarter)
4.27M10.86M-9.55M27.98M27.35M15.95M-30.83M65.69M19.03M-7.04M10.64M-21.47M1.38M0.61M-0.62M5.53M1.12M0.18M-1.27M0.37M
Sales of Property, Plant and Equipment (Quarter)
Change in Intangibles (Quarter)
21.23M
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)
31.93M12.23M0.60M-31.00M33.66M0.10M0.06M0.10M10.00M13.02M35.00M49.53M18.03M5.35M-5.35M5.35M25.58M
Cash from Investing Activities (Quarter)
31.84M10.49M10.58M-137.80M-69.31M116.67M-1.17M-18.89M-8.48M-8.60M-15.63M2.25M-35.62M-51.49M65.03M9.83M4.13M-16.14M-181.36M43.57M
Financing Activities
Other financing activities (Quarter)
2.62M1.40M-2.59M
Cash from Financing Activities (Quarter)
38.50M98.34M42.66M325.95M-0.30M-0.01M123.99M109.94M76.89M43.41M237.50M200.54M10.22M148.89M15.58M106.93M-0.98M172.81M173.52M54.89M
Additional items
Exchange Rate Effect (Quarter)
-0.11M0.05M0.04M0.07M-0.17M0.26M0.04M0.16M-0.25M-0.01M-0.00M-0.03M-0.04M0.01M0.01M-0.01M-0.01M0.08M-0.06M0.01M
Change in Cash (Quarter)
9.76M39.28M-19.43M116.58M-144.72M25.66M42.26M0.48M-16.16M-44.98M134.47M87.49M-132.42M-2.93M-18.14M31.61M-82.77M77.00M-76.81M28.09M
Free Cash Flow (Quarter)
-64.74M-80.46M-63.17M-99.62M-102.28M-107.20M-49.77M-156.42M-103.34M-72.73M-98.04M-93.80M-108.36M-100.95M-98.14M-90.67M-87.03M-79.98M-67.63M-70.71M
Net Cash Flow (Quarter)
9.87M39.23M-19.48M116.51M-144.54M25.41M42.22M0.32M-15.91M-44.97M134.47M87.52M-132.38M-2.94M-18.15M31.62M-82.76M76.87M-76.74M28.13M